Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Alberts

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Antibiotics|May 1, 1981
Dihydromevinolin, a potent hypocholesterolemic metabolite produced by Aspergillus terreusG Albers-Schönberg, H Joshua, M B Lopez, et al.
Journal of Medicinal Chemistry|August 1, 1991
3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. 7. Modification of the hexahydronaphthalene moiety of simvastatin: 5-oxygenated and 5-oxa derivativesM E Duggan, A W Alberts, R Bostedor, et al.
Journal of Medicinal Chemistry|October 16, 1992
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogsG D Hartman, W Halczenko, M E Duggan, et al.
Journal of Lipid Mediators|June 1, 1993
MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factorS B Hwang, M H Lam, D M Szalkowski, et al.
The American Journal of Pathology|September 1, 1988
Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductaseP H Berry, J S MacDonald, A W Alberts, et al.
Biochemical and Biophysical Research Communications|February 15, 1988
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonistM M Ponpipom, S B Hwang, T W Doebber, et al.
Journal of Medicinal Chemistry|September 18, 1992
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.
Journal of Medicinal Chemistry|February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivativesG E Stokker, A W Alberts, P S Anderson, et al.
Molecular Pharmacology|January 1, 1991
In vivo development and in vitro characterization of a subclone of murine P388 leukemia resistant to bis(diphenylphosphine)ethaneG D Hoke, F L McCabe, L F Faucette, et al.
Journal of Medicinal Chemistry|March 1, 1985
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 1. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivativesG E Stokker, W F Hoffman, A W Alberts, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Antibiotics|May 1, 1981
Dihydromevinolin, a potent hypocholesterolemic metabolite produced by Aspergillus terreusG Albers-Schönberg, H Joshua, M B Lopez, et al.
Journal of Medicinal Chemistry|August 1, 1991
3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. 7. Modification of the hexahydronaphthalene moiety of simvastatin: 5-oxygenated and 5-oxa derivativesM E Duggan, A W Alberts, R Bostedor, et al.
Journal of Medicinal Chemistry|October 16, 1992
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogsG D Hartman, W Halczenko, M E Duggan, et al.
Journal of Lipid Mediators|June 1, 1993
MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factorS B Hwang, M H Lam, D M Szalkowski, et al.
The American Journal of Pathology|September 1, 1988
Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductaseP H Berry, J S MacDonald, A W Alberts, et al.
Biochemical and Biophysical Research Communications|February 15, 1988
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonistM M Ponpipom, S B Hwang, T W Doebber, et al.
Journal of Medicinal Chemistry|September 18, 1992
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.
Journal of Medicinal Chemistry|February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivativesG E Stokker, A W Alberts, P S Anderson, et al.
Molecular Pharmacology|January 1, 1991
In vivo development and in vitro characterization of a subclone of murine P388 leukemia resistant to bis(diphenylphosphine)ethaneG D Hoke, F L McCabe, L F Faucette, et al.
Journal of Medicinal Chemistry|March 1, 1985
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 1. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivativesG E Stokker, W F Hoffman, A W Alberts, et al.
Pageof 10